Home > Healthcare > Medical Services > Inpatient and Outpatient Services > Basal Cell Carcinoma Treatment Market

Basal Cell Carcinoma Treatment Market Share

  • Report ID: GMI10474
  • Published Date: Jul 2024
  • Report Format: PDF

Basal Cell Carcinoma Treatment Market Share

The market is driven by continuous innovation and technological advancements. Leading companies offer a wide range of advanced cancer treatment including medications along with strategic initiatives to sustain the market competition. These companies are continually investing in research and development to introduce new products and enhance existing ones.
 

Basal Cell Carcinoma Treatment Companies

Prominent players operating in the basal cell carcinoma treatment industry include:

  • Service providers
    • Cleveland Clinic
    • Dana-Farber Cancer Institute, Inc
    • Medical Tours
    • The Johns Hopkins University
    • The Ohio State University
  • Medication manuafcturers  
    • Almirall, S.A
    • Bausch Health Companies Inc.
    • Dr. Reddy’s Laboratories Ltd.
    • F. Hoffmann-La Roche Ltd.
    • Genentech, Inc.
    • Merck & Co., Inc.
    • Mylan N.V.
    • Novartis AG
    • Sanofi
    • Sun Pharmaceutical Industries Ltd.
       
Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The basal cell carcinoma treatment market accounted for USD 7.1 billion in 2023 and is expected to grow at 8.6% CAGR driven by increasing incidence of basal cell carcinoma, primarily due to heightened exposure to UV radiations.

The nodular segment in the basal cell carcinoma treatment market held 66.5% share in 2023 as it is easier to detect early compared to other skin cancer subtypes.

North America basal cell carcinoma treatment industry is expected to record at 8.3% CAGR to reach USD 5.6 billion by 2032, owing to increasing disease incidence among aging population demographics, coupled with heightened awareness of skin cancer risks.

Almirall, S.A, Bausch Health Companies Inc., Dr. Reddy’s Laboratories Ltd., F. Hoffmann-La Roche Ltd., Genentech, Inc., Merck & Co., Inc., and Mylan N.V. among others

Basal Cell Carcinoma Treatment Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 15
  • Tables & Figures: 374
  • Countries covered: 22
  • Pages: 224
 Download Free Sample